Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.73 +0.01 (+0.09%)
At close: Aug 20, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Enterprise Value (2024 - 2025)

Drugs Made In America Acquisition's (DMAA) quarterly Enterprise Value came in at -$6137.0 in Q4 2025, down 354.26% YoY from $2413.7 in Q4 2024, and down 755.93% on a QoQ basis from -$717.0 in Q3 2025.

Drugs Made In America Acquisition (DMAA) Enterprise Value (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 2 years of Enterprise Value data on file, last reported at -$6137.0 in Q4 2025.

  • Quarterly Enterprise Value fell 354.26% year-over-year to -$6137.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6137.0 (down 354.26% YoY) and the FY2025 annual result came in at -$6137.0, down 354.26% from the prior year.
  • Enterprise Value declined to -$6137.0 in Q4 2025, from -$717.0 in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$717.0 in Q3 2025 to a low of -$6137.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - -250,000.00
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -174,974.00
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - -25,000.00
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -10,586.00
5 Aldel Financial 397.49 Mn 397.49 Mn - -283,112.00
6 Gores Holdings X 381.05 Mn 380.85 Mn - -194,541.00
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -250,000.00
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - -32,560.00
9 Berto Acquisition 313.96 Mn 313.81 Mn - -147,000.00
10 Drugs Made In America Acquisition 215.52 Mn 215.52 Mn - -20,280.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -6,137.00
Sep 30, 2025 -717.00
Jun 30, 2025 -822.00
Mar 31, 2025 -923.00
Dec 31, 2024 -1,351.00